News

Over 10% of the Irish public do not clean their face at all, while almost a third only use soap and water, new research suggests. In a survey conducted by McCabes Pharmacy, a fifth of respondents said they only wash...

Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products, has announced an agreement with Pfeiffer Vacuum Technologies to provide characterization testing of container-closure systems for the biopharma industry. US-based Pfeiffer Vacuum...

Pharmapack Europe (#PharmapackEU), announces the winners of the 2020 Pharmapack Awards. Due to the outstanding quality of entries, eight worthy winners were chosen across two categories: ‘Exhibitor Innovations’ and ‘Health Products’.  The Exhibitor Innovations category saw a total of six winners selected across four pharma categories,...

Pharmaceutical development expert, Velesco Pharma, is initiating operations at its new state-of-the-art cGMP clinical manufacturing facility in Wixom, Michigan. Set to triple the company’s cGMP clinical trial manufacturing capacity, the newly renovated building will feature expanded processing suite space to...

Applied Photophysics Limited, a world leader in biophysical characterization of biomolecules, has announced that its Board of Directors has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors effective immediately. Additionally, Marc Neglia has...

Catalent, Inc , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, and MaSTherCell Global, Inc., a technology-focused cell and gene therapy contract development and manufacturing organization...

Inceptua announced that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January, 2020. Paul will take on...